(MedPage Today) -- Two different antibodies had a similar impact on survival when added to chemotherapy for patients with newly diagnosed colorectal cancer, investigators reported. The study was among several notable reports from the European Society for Medical Oncology World Congress on Gastrointestinal Cancer. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment